4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-17-026974
Chief Executive Officer acquired 978,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Anzalone Christopher Richard · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-04-12 | Grant or award : show line 1 in the form | +978,000 | 1,794,789 | D |
Loading xslF345X03/doc4.xml…